Dr. Öğr. Üyesi DİLEK ÖZTÜRK CİVELEK

Yayın Ağı

Makaleler 32

1. The Impact of Liraglutide, a GLP-1 Receptor Agonist, on High Glucose-Induced Inflammation, Apoptosis, Oxidative Stress, and NLRP3 Signaling.

Gokce M., Ozturk Civelek D., Vidin Sen A., Guler E. M., CİVELEK E., UYDEŞ DOĞAN B. S., et al.

Cell biochemistry and biophysics , cilt.83, sa.3, ss.3619-3632, 2025 (SCI-Expanded, Scopus)

2. Synthesis, Cytotoxic Evaluation, and In Silico Studies of Novel Benzenesulfonamide-Thiazolidinone Derivatives Against Colorectal Carcinoma

Zengin Kurt B., Gökçe M., Şenol H., Öztürk Civelek D., Dandin G., Gazioğlu I.

JOURNAL OF MOLECULAR STRUCTURE , cilt.1321, ss.1-15, 2025 (SCI-Expanded, Scopus)

3. Curcumin-crosslinked single-chain polymer nanoparticles as potential polymer-drug conjugates

Batu H. K., Öztürk Civelek D., Temel B.

International Journal of Polymeric Materials and Polymeric Biomaterials , cilt.74, sa.18, ss.1672-1682, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Dosing-time, feeding, and sex-dependent variations of everolimus pharmacokinetics in mice

ÖZTÜRK CİVELEK D., ÖZTÜRK SEYHAN N., AKYEL Y. K., Gazioglu I., PALA KARA Z., Orman M. N., et al.

Fundamental and Clinical Pharmacology , cilt.38, sa.5, ss.883-896, 2024 (SCI-Expanded, Scopus)

5. The role of the circadian timing system on drug metabolism and detoxification: an update

Okyar A., Öztürk Civelek D., Akyel Y. K., Surme S., Pala Kara Z., Kavakli İ. H.

EXPERT OPINION ON DRUG METABOLISM AND TOXICOLOGY , cilt.2024520, sa.2024 May 20:1-15, ss.1-15, 2024 (SCI-Expanded, Scopus)

6. Novel 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide based thiosemicarbazides as potent and selective inhibitors of tumor-associated human carbonic anhydrase IX and XII: Synthesis, cytotoxicity, and molecular modelling studies

DEMİR YAZICI K., Trawally M., Bua S., ÖZTÜRK CİVELEK D., Akdemir A., Supuran C. T., et al.

Bioorganic Chemistry , cilt.144, 2024 (SCI-Expanded, Scopus)

7. Synthesis of Sorafenib−Ruthenium Complexes, Investigation of Biological Activities and Applications in Drug Delivery Systems as an Anticancer Agent

Zengin Kurt B., Öztürk Civelek D., Çakmak E. B., Kolcuoğlu Y., Şenol H., Sağlık Özkan B. N., et al.

JOURNAL OF MEDICINAL CHEMISTRY , cilt.67, sa.6, ss.4463-4482, 2024 (SCI-Expanded, Scopus)

8. Synthesis of naproxen thiadiazole urea hybrids and determination of their anti-melanoma, anti-migration, tyrosinase inhibitory activity, and molecular docking studies

ZENGİN KURT B., Altundağ Ö., GÖKÇE M., Cakmak U., Tuncay F. O., KOLCUOĞLU Y., et al.

Journal of Molecular Structure , cilt.1295, 2024 (SCI-Expanded, Scopus)

9. Development of Curcumin and Turmerone Loaded Solid Lipid Nanoparticle for Topical Delivery: Optimization, Characterization and Skin Irritation Evaluation with 3D Tissue Model

Aydin B., Sagiroglu A., Öztürk Civelek D., Gokce M., Bahadori F.

International Journal of Nanomedicine , cilt.19, ss.1951-1966, 2024 (SCI-Expanded, Scopus)

10. Synthesis of flurbiprofen thiadiazole urea derivatives and assessment of biological activities and molecular docking studies

ZENGİN KURT B., Altundağ Ö., Tokgöz M. N., ÖZTÜRK CİVELEK D., Tuncay F. O., Cakmak U., et al.

Chemical Biology and Drug Design , cilt.102, sa.6, ss.1458-1468, 2023 (SCI-Expanded, Scopus)

11. Circadian Dysfunction in Adipose Tissue: Chronotherapy in Metabolic Diseases

CİVELEK E., ÖZTÜRK CİVELEK D., AKYEL Y. K., KALELİ DURMAN D., OKYAR A.

Biology , cilt.12, sa.8, 2023 (SCI-Expanded, Scopus)

12. Investigation the role of nitric oxide pathway in TNF-α induced HUVEC cells

CIVELEK E., CIVELEK D.

Journal of research in pharmacy (online) , cilt.27, sa.4, ss.1560-1566, 2023 (ESCI, Scopus, TRDizin)

13. Diurnal Changes in Capecitabine Clock-Controlled Metabolism Enzymes Are Responsible for Its Pharmacokinetics in Male Mice.

Akyel Y. K., Öztürk Civelek D., Ozturk Seyhan N., Gul Ş., Gazioglu I., Pala Kara Z., et al.

Journal of biological rhythms , cilt.38, sa.2, ss.171-184, 2023 (SCI-Expanded, Scopus)

14. Tail-Approach-Based Design and Synthesis of Coumarin-Monoterpenes as Carbonic Anhydrase Inhibitors and Anticancer Agents

Kurt B., Celebi G., Öztürk Civelek D., Angeli A., Akdemir A., Sonmez F., et al.

ACS Omega , cilt.8, sa.6, ss.5787-5807, 2023 (SCI-Expanded, Scopus)

15. The effect of biocompatible carriers with vitamin D and platelet-rich plasma (PRP) on bone defects

Turgut C., Ozturk Civelek D., Kotil T., GÜNGÖR S., Ozsoy Y., DİRİCAN A., et al.

Hippokratia , cilt.27, sa.2, ss.48-56, 2023 (SCI-Expanded, Scopus)

16. Design of Biocompatible Multifunctional Hydrogels with Stearyl Methacrylate and Vinylpyrrolidone

Kilic H., TUNCABOYLU D. C., Argun A., ÖZTÜRK CİVELEK D.

ACS APPLIED POLYMER MATERIALS , cilt.4, sa.3, ss.1717-1727, 2022 (SCI-Expanded, Scopus)

17. Evaluation of the Immunomodulatory Effects of C-Vx on the Innate and Adaptive"Immune" System:Preliminary Results

Oktelık F., Cıvelek D., Okyar A., Aktas E., Kucuksezer U., Akdenız N., et al.

JOURNAL OF COMPLEMENTARY MEDICINE RESEARCH , cilt.14, sa.1, ss.135-144, 2022 (ESCI) Sürdürülebilir Kalkınma

18. Dosing-time dependent testicular toxicity of everolimus in mice.

Ozturk N., Ozturk Civelek D., Sancar S., Kaptan E., Pala Kara Z., Okyar A.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences , cilt.165, ss.105926, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Quinoline-sulfamoyl carbamates/sulfamide derivatives: Synthesis, cytotoxicity, carbonic anhydrase activity, and molecular modelling studies

Cakmak E. B., Zengin Kurt B., Ozturk Civelek D., Angeli A., Akdemir A., Sonmez F., et al.

Bioorganic Chemistry , cilt.110, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. The Effects of P-glycoprotein Inhibitor Zosuquidar on the Sex and Time-Dependent Pharmacokinetics of Parenterally Administered Talinolol in Mice.

Kara Z., Ozturk D., Ozturk N., Okyar A.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences , cilt.156, 2021 (SCI-Expanded, Scopus)

21. The Association of ABCC5 and ABCC11 Polymorphisms with The Pharmacokinetics of 5-FU in Advanced Gastric Cancer Patients

Pala Kara Z., Öztaş E., Öztürk D., Akyel Y. K., Turna Z. H., Okyar A., et al.

Clinical and Experimental Health Science , cilt.10, sa.3, ss.285-291, 2020 (ESCI, TRDizin) Sürdürülebilir Kalkınma

22. Effects of atorvastatin on talinolol absorption: A potential drug-drug interaction

Kara Z. P., Ozturk D., ÖZTÜRK N., Orman M., Baktir G., OKYAR A.

Die Pharmazie , cilt.75, sa.2, ss.70-74, 2020 (SCI-Expanded, Scopus)

23. Association between ABCB1, ABCG2 carrier protein and COX-2 enzyme gene polymorphisms and breast cancer risk in a Turkish population

Kara Pala Z., Dilek O., Ezgi O., Halil K., Cihan U., Gul O.

Saudi Pharmaceutical Journal , cilt.28, sa.2, ss.215-219, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. HT29 Hücre Hattında Sirkadiyen Ritme Bağlı Gen İfadesinin Kontrolünde Referans Gen Farklılığının Senkronizasyondaki Rolü

Göncü B. S., Öztürk D.

Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi , cilt.12, sa.3, ss.1370-1380, 2020 (TRDizin)

25. HT-29 Kolon Kanser Hücre Hattında Senkronizasyon Başlatıcıların Sirkadiyen Ritimdeki Rolü

Öztürk D., Göncü B. S.

Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi , cilt.9, sa.4, 2019 (TRDizin)

26. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies

ZENGİN KURT B., SÖNMEZ F., ÖZTÜRK D., AKDEMİR A., Angeli A., Supuran C. T.

European Journal Of Medicinal Chemistry , cilt.183, ss.111702, 2019 (SCI-Expanded, Scopus)

27. Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients

Yuksel M. K., Öztürk D., Oztas E., Ozhan G., Turker A. A., Korkmaz T., et al.

ISTANBUL JOURNAL OF PHARMACY , cilt.49, sa.2, ss.64-69, 2019 (ESCI, TRDizin)

28. A new dinuclear copper (II) complex of 2,5-Furandicarboxyclic acid with 4(5)-Methylimidazole as a high potential α-glucosidase inhibitor: Synthesis, Crystal structure, Cytotoxicity study, and TD/DFT calculations

AVCI D., Altürk S., SÖNMEZ F., TAMER Ö., BAŞOĞLU A., ATALAY Y., et al.

Applied Organometallic Chemistry , cilt.33, sa.3, ss.4725, 2019 (SCI-Expanded, Scopus)

29. The immune system as a chronotoxicity target of the anticancer mTOR inhibitor everolimus.

OZTURK N., Ozturk D., PALA-KARA Z., KAPTAN E., SANCAR-BAS S., OZSOY N., et al.

Chronobiology international , cilt.35, ss.705-718, 2018 (SCI-Expanded, Scopus)

30. Molecular aspects of circadian pharmacology and relevance for cancer chronotherapy

ÖZTÜRK N., Ozturk D., Kavakli I. H., OKYAR A.

International Journal of Molecular Sciences , cilt.18, sa.10, 2017 (SCI-Expanded, Scopus)

31. Pharmacokinetics of talinolol is modified by barnidipine: Implication of P-glycoprotein modulation

ÖZTÜRK N., Ozturk D., Pala-Kara Z., OKYAR A.

Pharmazie , cilt.72, sa.1, ss.29-34, 2017 (SCI-Expanded, Scopus)

32. ABC taşıyıcı proteinleri: Sirkadiyan ritimler ve cinsiyete bağlı farklılıklar

Pala Kara Z., Öztürk N., ÖZTÜRK D., Okyar A.

Journal of Marmara University Institute of Health Sciences , cilt.3, sa.1, ss.1-13, 2013 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 26

1. Porfirin Klik Çapraz Bağlayıcısı ile Tek-Zincir Polimer Nanopartiküllerin Sentezi ve Karakterizasyonu

Demir Z., Samuk E., Temel B., Temel İ. G., Öztürk Civelek D., Karaca Balta D.

IX. Uluslararası Katılımlı Polimer Bilim ve Teknolojisi Kongresi, Ankara, Türkiye, 16 - 18 Eylül 2024, ss.392, (Özet Bildiri) Sürdürülebilir Kalkınma

2. Porphyrin-Based Single-Chain Polymer Nanoparticles for Photodynamic Therapy

Temel B., Demir Z., Samuk E., Temel İ. G., Öztürk Civelek D., Karaca Balta D.

International Conference on Nanomedicine and Nanobiotechnology – ICONAN 2024, Barcelona, İspanya, 15 - 17 Ocak 2024, ss.162-163, (Özet Bildiri) Sürdürülebilir Kalkınma